|
Re: BETonMACE Cognition Sub-Study Published
|
5
|
Resverlogix Corp.
|
Sep 01, 2021 12:26PM
|
|
Re: BioSpace-Amgen's Repatha
|
3
|
Resverlogix Corp.
|
Nov 16, 2017 09:57AM
|
|
Re: Chart is looking good....
|
4
|
Resverlogix Corp.
|
Aug 17, 2016 02:47PM
|
|
Re: Constellation Pharma
|
12
|
Resverlogix Corp.
|
Jun 30, 2020 08:29AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
4
|
Resverlogix Corp.
|
Dec 16, 2021 02:17PM
|
|
Re: Courtesy
|
4
|
Resverlogix Corp.
|
Aug 22, 2017 04:31PM
|
|
Re: Curiouser and Curiouser....
|
4
|
Resverlogix Corp.
|
May 01, 2017 04:07PM
|
|
Re: Enrollment
|
2
|
Resverlogix Corp.
|
Aug 22, 2016 04:42PM
|
|
Re: Enrollment
|
6
|
Resverlogix Corp.
|
Aug 22, 2016 02:52PM
|
|
Re: Entresto Trial (Novartis)
|
4
|
Resverlogix Corp.
|
Jun 24, 2020 02:47AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
6
|
Resverlogix Corp.
|
May 26, 2017 08:37AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
6
|
Resverlogix Corp.
|
May 26, 2017 09:18AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
3
|
Resverlogix Corp.
|
May 26, 2017 04:01PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
2
|
Resverlogix Corp.
|
May 26, 2017 04:27PM
|
|
Re: From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
5
|
Resverlogix Corp.
|
Oct 21, 2020 02:28PM
|
|
Re: HL
|
5
|
Resverlogix Corp.
|
Nov 17, 2017 03:34PM
|
|
Re: HL
|
7
|
Resverlogix Corp.
|
Nov 17, 2017 03:55PM
|
|
Re: I'll keep my opinions
|
4
|
Resverlogix Corp.
|
Sep 12, 2016 03:51PM
|
|
Re: Important article published yesterday (January 4), RVX208 relevant
|
4
|
Resverlogix Corp.
|
Jan 05, 2019 12:23PM
|
|
Re: Is this relevant to RVX
|
5
|
Resverlogix Corp.
|
May 17, 2020 11:21AM
|
